Study Complete
Sponsor ID
20050242
Randomized, Placebo-controlled, Double-blind, Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple, Oral Administration of AMG 221 in Overweight and Obese Subjects
Study Details
Protocol Summary
Primary Outcome Measures
Not Available
Secondary Outcome Measures
Not Available
Study Documents
Study Synopsis
Available Language(s): English
Locations
No locations found.